Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 3/20 | 0.57 |
| ▸ | PPARG | P37231 | 4/20 | 0.56 |
| ▸ | PPARA | Q07869 | 4/20 | 0.56 |
| ▸ | TERT | O14746 | 3/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.55 |
| ▸ | BLM | P54132 | 2/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.55 |
| ▸ | FABP4 | P15090 | 2/20 | 0.55 |
| ▸ | FAAH | O00519 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | PPARD | Q03181 | 2/20 | 0.55 |
| ▸ | GMNN | O75496 | 1/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7552771 | 1.00 | FABP3 (0.57) | FABP3PPARGPPARATERTPTPN1 | |
| SCHEMBL6424763 | 1.00 | FABP3 (0.57) | FABP3PPARGPPARATERTPTPN1 | |
| SCHEMBL4200342 | 1.00 | FABP3 (0.57) | FABP3PPARGPPARATERTPTPN1 | |
| SCHEMBL7552935 | 1.00 | FABP3 (0.57) | FABP3PPARGPPARATERTPTPN1 | |
| SCHEMBL5066940 | 1.00 | FABP3 (0.57) | FABP3PPARGPPARATERTPTPN1 | |
| SCHEMBL4200339 | 1.00 | FABP3 (0.57) | FABP3PPARGPPARATERTPTPN1 | |
| SCHEMBL6424766 | 1.00 | FABP3 (0.57) | FABP3PPARGPPARATERTPTPN1 | |
| SCHEMBL4203778 | 1.00 | FABP3 (0.57) | FABP3PPARGPPARATERTPTPN1 | |
| SCHEMBL501714 | 1.00 | FABP3 (0.57) | FABP3PPARGPPARATERTPTPN1 | |
| SCHEMBL7781593 | 1.00 | FABP3 (0.57) | FABP3PPARGPPARATERTPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112237628-A | EBV-targeted LMP2-mRNA nano vaccine | 四川大学华西医院 | 2021-01-19 | — | — | CN | claimed |
| CN-112180079-A | Stable liposome particles and application thereof in immunoturbidimetric assay | 上海睿康生物科技有限公司 | 2021-01-05 | — | — | CN | claimed |
| EP-1551370-A1 | AGGREGATE WITH INCREASED DEFORMABILITY, COMPRISING AT LEAST THREE AMPHIPATS, FOR IMPROVED TRANSPORT THROUGH SEMI-PERMEABLE BARRIERS AND FOR THE NON-INVASIVE DRUG APPLICATION IN VIVO, ESPECIALLY THROUGH THE SKIN | IDEA AG (DE) | 2005-07-13 | — | — | EP | claimed |
| WO-2004032900-A1 | AGGREGATE WITH INCREASED DEFORMABILITY, COMPRISING AT LEAST THREE AMPHIPATS, FOR IMPROVED TRANSPORT THROUGH SEMI-PERMEABLE BARRIERS AND FOR THE NON-INVASIVE DRUG APPLICATION IN VIVO, ESPECIALLY THROUGH THE SKIN | IDEA AG (DE) | 2004-04-22 | — | — | WO | claimed |
| WO-2023190166-A1 | CATIONIC LIPID HAVING DISULFIDE BOND, LIPID MEMBRANE STRUCTURE INCLUDING SAME, NUCLEIC ACID INTRODUCTION AGENT AND PHARMACEUTICAL COMPOSITION CONTAINING ANY ONE OF SAME, METHOD FOR INTRODUCING NUCLEIC ACID INTO CELL OR TARGET CELL, AND METHOD FOR PRODUCING CELLULAR PHARMACEUTICAL | 日油株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023190170-A1 | METHOD FOR PRODUCING NUCLEIC ACID-ENCAPSULATED LIPID NANOPARTICLES, METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITION CONTAINING SAID LIPID NANOPARTICLES, AND METHOD FOR INTRODUCING NUCLEIC ACID INTO CELL OR TARGET CELL | 日油株式会社 | 2023-10-05 | — | — | WO | disclosed |
| CN-112237628-A | EBV-targeted LMP2-mRNA nano vaccine | 四川大学华西医院 | 2021-01-19 | — | — | CN | disclosed |
| CN-112180079-A | Stable liposome particles and application thereof in immunoturbidimetric assay | 上海睿康生物科技有限公司 | 2021-01-05 | — | — | CN | disclosed |
| US-8906279-B2 | Manufacturing method of polarizing plate protective film, polarizing plate protective film, polarizing plate, and liquid crystal display device | KONICA MINOLTA OPTO, INC. (JP) | 2014-12-09 | — | — | US | disclosed |
| US-8569405-B2 | Additive mixtures for styrenic polymers | BASF SE (DE) | 2013-10-29 | — | — | US | disclosed |
| US-8518302-B2 | Stabilization of organic materials | BASF SE (DE) | 2013-08-27 | — | — | US | disclosed |
| US-20120088869-A1 | STABILIZATION OF ORGANIC MATERIALS | GERSTER MICHELE (CH) | 2012-04-12 | — | — | US | disclosed |
| US-5369159-A | Heat, oxidation and radiation resistance for polymers | CIBA-GEIGY CORPORATION (US) | 1994-11-29 | — | — | US | disclosed |
| US-5367008-A | 3-(alkoxyphenyl)benzofuran-2-ones as stabilisers | CIBA-GEIGY CORPORATION (US) | 1994-11-22 | — | — | US | disclosed |
| US-5356966-A | Stabilizing organic material against oxidative, thermal or light iinduced degradation | CIBA-GEIGY CORPORATION (US) | 1994-10-18 | — | — | US | disclosed |
| EP-0608198-A1 | Cyclic diphenylacetonenitriles as stabilisers | CIBA-GEIGY AG (CH) | 1994-07-27 | — | — | EP | disclosed |
| EP-0591102-A1 | 3-(2-Acyloxyethoxyphenyl)benzofuran-2-ones as stabilizers | CIBA-GEIGY AG (CH) | 1994-04-06 | — | — | EP | disclosed |
| EP-0589839-A1 | 3-(Dihydrobenzofuran-5-yl)benzofuran-2-ones as stabilizers | CIBA-GEIGY AG (CH) | 1994-03-30 | — | — | EP | disclosed |
| US-5216052-A | Useful for stabilization of synthetic polymers against oxidative, thermal and light-induced degradation | CIBA-GEIGY CORPORATION (US) | 1993-06-01 | — | — | US | disclosed |
| WO-1992003122-A1 | PREPARATION FOR APPLICATION OF ACTIVE SUBSTANCES IN THE FORM OF MINIMUM-SIZED DROPLETS | CEVC GREGOR (DE) | 1992-03-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088869-A1 | STABILIZATION OF ORGANIC MATERIALS | LPO, AOX1, SOD1 | FABP3 3633/4885PPARG 890/4885PPARA 766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.